MacroGenics, Inc. (NASDAQ:MGNX) Q4 2021 Results Conference Call February 24, 2022 4:30 PM ET Company Participants Christopher James - Vice President of Investor Relations and Corporate Communications Scott Canning - President and Chief Executive Officer James Karrels - Senior Vice President and Chief Financial Office Conference Call Participants Kaveri Pohlman - BTIG Etzer Darout - BMO Capital Markets Asha Babaric - Citi Charles Zhu - Guggenheim Jonathan Miller - Evercore ISI Stephen Willey - Stifel Silvan ...

® Developing Breakthrough Biologics, Life-changing Medicines® Corporate Update January 10, 2022 The information in this slide deck is current as of January 10, 2022, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports filed with the SEC. MacroGenics undertakes no obligation to update any of the information herein. Cautionary Note on Forward-Looking Statements 2 Legal Notices Any statements in these materials about future expectations, p ...

® Developing Breakthrough Biologics, Life-changing Medicines® Corporate Update November 2, 2021 The information in this slide deck is current as of November 2, 2021, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports filed with the SEC. MacroGenics undertakes no obligation to update any of the information herein. Cautionary Note on Forward-Looking Statements 2 Legal Notices Any statements in these materials about future expectations, p ...

MacroGenics, Inc. (NASDAQ:MGNX) Q3 2021 Earnings Conference Call November 2, 2021 4:30 PM ET Company Participants Chris James - Vice President of Investor Relations and Corporate Communications Scott Koenig - President and Chief Executive Officer Jim Karrels - Chief Financial Officer Conference Call Participants Peter Lawson - Barclays Kaveri Pohlman - BTIG Asha Babaric - Citi Jonathan Chang - SVB Leerink Jonathan Miller - Evercore ISI Silvan Tuerkcan - JMP Securities Stephen Willey - Stifel Avatar Jones - ...

MACRO GENICS® Developing Breakthrough Biologics, Life-changing Medicines® Corporate Update September 16, 2021 The information in this slide deck is current as of September 16, 2021, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports filed with the SEC. MacroGenics undertakes no obligation to update any of the information herein. Cautionary Note on Forward-Looking Statements September 16, 2021 2 Legal Notices Trademarks DART, TRIDENT, M ...

MacroGenics, Inc. (NASDAQ:MGNX) Q2 2021 Earnings Conference Call July 29, 2021 4:30 PM ET Company Participants Chris James ??? Vice President of Investor Relations and Corporate Communications Scott Koenig ??? President and Chief Executive Officer Jim Karrels ??? Chief Financial Officer Conference Call Participants Carly Kenselaar ??? Citi Jonathan Chang ??? SVB Leerink Jonathan Miller ??? Evercore ISI Stephen Willey ??? Stifel Etzer Darout ??? Guggenheim Securities Cynthia Cintron ??? Cowen Peter Lawson ?? ...

® Corporate Presentation April 29, 2021 The information in this slide deck is current as of April 29, 2021, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports filed with the SEC. MacroGenics undertakes no obligation to update any of the information herein. Cautionary Note on Forward-Looking Statements 2 Legal Notices Any statements in these materials about future expectations, plans and prospects for MacroGenics ("Company"), including ...

MacroGenics, Inc. (NASDAQ:MGNX) Q1 2021 Earnings Conference Call April 29, 2021 4:30 PM ET Company Participants Anna Krassowska - Investor Relations Scott Koenig - President & Chief Executive Officer Jim Karrels - Senior Vice President & Chief Financial Officer Conference Call Participants Jonathan Chang - SVB Leerink Peter Lawson - Barclays Jonathan Miller - Evercore ISI Stephen Willey - Stifel Yigal Nochomovitz - Citigroup Bradley Canino - Credit Suisse Etzer Darout - Guggenheim Securities David Lebowitz ...

® Corporate Presentation February 25, 2021 The information in this slide deck is current as of February 25, 2021, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics' Annual, Quarterly and Current Reports filed with the SEC. MacroGenics undertakes no obligation to update any of the information herein. Cautionary Note on Forward-Looking Statements 2 Legal Notices Any statements in these materials about future expectations, plans and prospects for MacroGenics ("Company"), incl ...

MacroGenics, Inc. (NASDAQ:MGNX) Q4 2020 Earnings Conference Call February 25, 2020 4:30 PM ET Company Participants Anna Krassowska - Investor Relations Scott Koenig - President and Chief Executive Officer Jim Karrels - Senior Vice President and Chief Financial Officer Conference Call Participants Evan Seigerman - Credit Suisse David Ruch - SVB Leerink Bo Chen - Evercore ISI David Lebowitz - Morgan Stanley Mitchell Kapoor - Barclays Operator Good afternoon. We will begin the MacroGenics 2020 Fourth Quarter a ...